Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
AstraZeneca
Johnson and Johnson
Baxter
Medtronic

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Carboxyamidotriazole

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Carboxyamidotriazole?

Carboxyamidotriazole is an investigational drug.

There have been 10 clinical trials for Carboxyamidotriazole. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 1999.

The most common disease conditions in clinical trials are Glioma, Kidney Neoplasms, and Carcinoma, Renal Cell. The leading clinical trial sponsors are National Cancer Institute (NCI), Tactical Therapeutics, Inc., and Annick Desjardins.

Recent Clinical Trials for Carboxyamidotriazole
TitleSponsorPhase
Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent GliomaTactical Therapeutics, Inc.Phase 1
Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent GliomaAnnick DesjardinsPhase 1
Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab FailureTactical Therapeutics, Inc.Phase 1

See all Carboxyamidotriazole clinical trials

Clinical Trial Summary for Carboxyamidotriazole

Top disease conditions for Carboxyamidotriazole
Top clinical trial sponsors for Carboxyamidotriazole

See all Carboxyamidotriazole clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Colorcon
Express Scripts
Boehringer Ingelheim
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.